BlackBarn Capital Partners LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
BlackBarn Capital Partners LP disclosed 11 US equity positions worth $278.9m in its Q4 2025 13F filing. The largest position was ROIV at 24.0% of the reported book, followed by DHC and PRVA. Against the Q3 2025 filing, it opened 1 new position, added to 6 and reduced 4 among the top 11 holdings.
What did BlackBarn Capital Partners LP own in Q4 2025? Top 11 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ROIV ROIVANT SCIENCES LTD | Healthcare | 24.0% | $66.9m | 3,084,300 | -30% | reduced |
| 2 | DHC DIVERSIFIED HEALTHCARE TR | 11.4% | $31.7m | 6,530,140 | 6% | added | |
| 3 | PRVA PRIVIA HEALTH GROUP INC | Healthcare | 11.1% | $30.8m | 1,300,000 | 19% | added |
| 4 | NIQ NIQ GLOBAL INTELLIGENCE PLC | 10.6% | $29.7m | 1,800,000 | – | new | |
| 5 | NEE NEXTERA ENERGY INC | Utilities | 9.6% | $26.9m | 335,000 | 24% | added |
| 6 | MH MCGRAW HILL INC | 8.3% | $23.1m | 1,400,000 | 65% | added | |
| 7 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 7.1% | $19.8m | 1,570,000 | -28% | reduced |
| 8 | VKTX VIKING THERAPEUTICS INC | Healthcare | 6.9% | $19.3m | 550,000 | 10% | added |
| 9 | CCOI COGENT COMMUNICATIONS HLDGS | Communication Services | 5.0% | $14.0m | 650,000 | 73% | added |
| 10 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 3.2% | $8.9m | 1,850,000 | -7% | reduced |
| 11 | ACLS AXCELIS TECHNOLOGIES INC | Technology | 2.8% | $7.8m | 96,573 | -52% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.